Travel industry since the time countries first started shutting down, to the reopening of nations around the world has been struggle a lot. Traveling during covid-19 pandemic is just about as hard as its going to get. Nevertheless, a birth of a new alternative vaccine is a solution for not only travel-holic but also for the whole industry. According to Pfizer’s report which was disclosed on , a new covid-19 vaccine – vaccine BNT162b2 is right around the corner. Since then, the covid-19 pandemic will be soon repelled, as a result, travel industry will come back to daily live as it used to be.
In term of a sharp increase in the number of people infected with nCoV in the US and Europe, the pharmaceutical company Pfizer (USA) and its partner BioNTech (Germany) have announced the preliminary results of the BNT162b2 vaccine robustly effective in preventing Covid-19 to more than 90% of protection effect assessment which is considered as a breakthrough in the race to find methods to repel the pandemic. This news gives hope to the whole world in every aspect.
Accordingly, Pfizer has done a research on the BNT162b2 vaccine among 44,000 participants whose age from 18 to over 65. The first analysis was based on 94 volunteers who developed Covid-19 has shown positive result. The result that Pfizer and BioNTech have announced surpass community expectation and also pass the safety 50% that FDA requires for a new vaccine. The USA plans to get the Pfizer vaccine this December due to the announcement of Health Minister Alex Azar launched on 10/11.
“This is really a spectacular number,” said Akiko Iwasaki, an immunologist at Yale University. “I wasn’t expecting it to be this high. I was preparing myself for something like 55 percent.” “If the final vaccine ends up with that level of efficacy, it would be higher than your regular flu vaccine, and this vaccine could have a serious impact on bending the curve of this outbreak,” said Dr. Saad B. Omer, the director of the Yale Institute for Global Health.
At the time, Moderna – A pharmaceutical maker also used genetic engineering, similar to Pfizer and BioNTech, to make vaccines. Trials were conducted in China, the UK, India, Singapore, Korea and Thailand.
The data analysis of the new vaccine – BNT162b2 vaccine, however, was just the preliminary research, Covid-19 still continues to threat people life. Even so, basing on the results that the above study has achieve, we can definitely expect for a bright future in this pandemic.
In the near future, when BNT162b2 vaccine and many other vaccines successfully modulated and released to the public, there will be no barrier for our travel hobby. ” I expect to see 2021… as 70% of what 2019 was and 2022 to be the year we’re back” – said Dow – the most optimistic of the experts USA TODAY. In the early 2021, flight restrictions, strict entry requirements and quarantines will be step by step lifted.